Researchers find potential target to prevent CRC spread

09/14/2011 | Genetic Engineering & Biotechnology News

Vanderbilt University researchers said a protein called blood vessel epicardial substance may be a potential drug target for preventing the spread of colorectal cancer. They reported in the Journal of Clinical Investigation that BVES is downgraded in colorectal cancer, which leads to cancer spread, but that reintroducing it can stop cells from beginning the metastasis process.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY